Compare CALX & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CALX | HTFL |
|---|---|---|
| Founded | 1999 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.2B |
| IPO Year | 2009 | 2025 |
| Metric | CALX | HTFL |
|---|---|---|
| Price | $32.94 | $46.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 9 |
| Target Price | $57.67 | ★ $65.00 |
| AVG Volume (30 Days) | 973.0K | ★ 1.6M |
| Earning Date | 11-02-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 157.78 | 82.37 |
| EPS | ★ 0.58 | N/A |
| Revenue | ★ $510,367,000.00 | $176,034,000.00 |
| Revenue This Year | $18.87 | $49.74 |
| Revenue Next Year | $15.46 | $24.54 |
| P/E Ratio | $57.79 | ★ N/A |
| Revenue Growth | 11.24 | ★ 39.92 |
| 52 Week Low | $30.71 | $20.13 |
| 52 Week High | $61.91 | $60.66 |
| Indicator | CALX | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 43.54 | 39.82 |
| Support Level | $32.35 | $22.47 |
| Resistance Level | $41.02 | $52.38 |
| Average True Range (ATR) | 1.43 | 3.68 |
| MACD | 0.02 | -1.47 |
| Stochastic Oscillator | 43.41 | 13.99 |
Calix Inc develops, markets and sells its appliance-based platform, cloud and managed services that enable service providers of all types and sizes to innovate and transform their businesses. The company's customers utilize the real-time data and insights from Calix platforms to simplify their business and deliver experiences that excite their subscribers. The resulting growth in subscriber acquisition, loyalty and revenue creates more value for their businesses and communities. The Company's revenue is principally derived in the United States and it also has its presence in Europe, Americas excluding U.S., and Rest of World.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.